Altered glycosylation in cancer: A promising target for biomarkers and therapeutics

D Thomas, AK Rathinavel, P Radhakrishnan - Biochimica et Biophysica …, 2021 - Elsevier
Glycosylation is a well-regulated cell and microenvironment specific post-translational
modification. Several glycosyltransferases and glycosidases orchestrate the addition of …

Biomarkers in stress related diseases/disorders: diagnostic, prognostic, and therapeutic values

K Dhama, SK Latheef, M Dadar, HA Samad… - Frontiers in molecular …, 2019 - frontiersin.org
Various internal and external factors negatively affect the homeostatic equilibrium of
organisms at the molecular to the whole-body level, inducing the so-called state of stress …

Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame

V Marotta, MC Zatelli, C Sciammarella… - Endocrine-related …, 2018 - erc.bioscientifica.com
Owing to the heterogeneity of neuroendocrine neoplasms (NENs), the availability of reliable
circulating markers is critical for improving diagnostics, prognostic stratification, follow-up …

Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes

S Mirhadi, S Tam, Q Li, N Moghal, NA Pham… - Nature …, 2022 - nature.com
Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. Only
a fraction of NSCLC harbor actionable driver mutations and there is an urgent need for …

Management of appendix neuroendocrine neoplasms: insights on the current guidelines

A Mohamed, S Wu, M Hamid, A Mahipal, S Cjakrabarti… - Cancers, 2022 - mdpi.com
Appendiceal neuroendocrine neoplasms (ANENs) usually present as incidental findings at
the time of appendectomy for acute appendicitis. They are rare, accounting for only 0.5–1 …

Circulating neuroendocrine tumor biomarkers: past, present and future

P Komarnicki, J Musiałkiewicz, A Stańska… - Journal of Clinical …, 2022 - mdpi.com
Neuroendocrine tumors are a heterogeneous group of neoplasms originating from the
diffuse endocrine system. Depending on primary location and hormonal status, they range in …

Current biomarkers for carotid artery stenosis: a comprehensive review of the literature

H Khan, F Shaikh, MH Syed, M Mamdani, G Saposnik… - Metabolites, 2023 - mdpi.com
Carotid artery stenosis (CAS), an atherosclerotic disease of the carotid artery, is one of the
leading causes of transient ischemic attacks (TIA) and cerebrovascular attacks (CVA). The …

[HTML][HTML] Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations

GB Mpilla, PA Philip, B El-Rayes… - World Journal of …, 2020 - ncbi.nlm.nih.gov
Pancreatic neuroendocrine tumors (PNETs) are known to be the second most common
epithelial malignancy of the pancreas. PNETs can be listed among the slowest growing as …

Pediatric adrenocortical tumours

EM Pinto, GP Zambetti, C Rodriguez-Galindo - Best Practice & Research …, 2020 - Elsevier
Childhood adrenocortical tumors (ACTs) are rare, representing∼ 0.2% of all pediatric
malignancies and having an incidence of 0.2–0.3 new cases per million per year in the …

[HTML][HTML] The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors

A Malczewska, B Kos-Kudła, M Kidd, I Drozdov… - Advances in medical …, 2020 - Elsevier
Purpose There are few effective biomarkers for neuroendocrine tumors. Precision oncology
strategies have provided liquid biopsies for real-time and tailored decision-making. This has …